Step 1 of 2
Older adults are at increased risk for tardive dyskinesia (TD), but symptoms may be overlooked amid cognitive impairment, polypharmacy, mobility limitations, and other comorbidities common in geriatric care. This downloadable slideset examines practical strategies for recognizing and assessing TD across primary care, long-term care, and community settings, including structured screening with AIMS and differentiation from other movement disorders. Learners will also review evidence-based management approaches, including individualized use of FDA-approved VMAT2 inhibitors and considerations specific to older adults.